{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:15:15Z","timestamp":1769760915607,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.brachy.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T08:48:02Z","timestamp":1605948482000},"page":"302-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-1675","authenticated-orcid":false,"given":"Nicki","family":"Groom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatman","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.10.002_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate after-loading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.10.002_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.radonc.2016.09.016","article-title":"A combined single high-dose rate brachytherapy boost with hypo fractionated external beam radiotherapy results in a high rate of biochemical disease-free survival in localised intermediate and high-risk prostate cancer patients","volume":"121","author":"Joseph","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.10.002_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2017.06.012","article-title":"High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypo fractionated regimens and clinical outcomes","volume":"124","author":"Vigneault","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.10.002_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.brachy.2017.06.013","article-title":"High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes","volume":"16","author":"Falk","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.10.002_bib6","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.urology.2013.08.036","article-title":"SIU\/ICUD consultation on urethral strictures: Posterior urethral stenosis after treatment of prostate cancer","volume":"83","author":"Herschorn","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2020.10.002_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.radonc.2014.10.007","article-title":"Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer","volume":"113","author":"D\u00edez","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2020.10.002_bib8","article-title":"Report 50","volume":"26","author":"Landberg","year":"1993","journal-title":"J Int Comm Radiat Units Measur"},{"issue":"1","key":"10.1016\/j.brachy.2020.10.002_bib9","article-title":"Report 62","volume":"32","author":"Landberg","year":"1999","journal-title":"J Int Comm Radiat Units Measur"},{"issue":"1","key":"10.1016\/j.brachy.2020.10.002_bib10","article-title":"Report 83","volume":"10","year":"2010","journal-title":"J Int Comm Radiat Units Measur"},{"issue":"1106","key":"10.1016\/j.brachy.2020.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190760","article-title":"A pilot study on dosimetric and radiomics analysis of urethral strictures following HDR brachytherapy as monotherapy for localized prostate cancer","volume":"93","author":"Tsang","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2020.10.002_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2020.10.002_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2009.09.015","article-title":"Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer","volume":"93","author":"Simnor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.10.002_bib15","unstructured":"Common terminology criteria for adverse events (CTCAE) version 5.0 (April 1, 2018)."},{"key":"10.1016\/j.brachy.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2005.02.015","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.10.002_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2014.08.061","article-title":"Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both","volume":"67","author":"Jarosek","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.10.002_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4111\/icu.2016.57.5.309","article-title":"Urethral strictures after radiation therapy for prostate cancer","volume":"57","author":"Moltzahn","year":"2016","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.brachy.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/pgmj.2005.042945","article-title":"Management of urethral strictures","volume":"82","author":"Mundy","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.brachy.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajur.2015.04.005","article-title":"Current trends in urethral stricture management","volume":"1","author":"Hillary","year":"2014","journal-title":"Asian J Urol"},{"key":"10.1016\/j.brachy.2020.10.002_bib23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/iju.14045","article-title":"Relationship between the dose to the bulbomembranous urethra and stricture after high dose-rate brachytherapy for prostate cancer: Matched-pair analysis","volume":"26","author":"Sekiguchi","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.brachy.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:35Z","timestamp":1761531335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472120302208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1538472120302208"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.10.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}